Latest News

Article Published in the MLO in the USA Shows the Benefit of Plasma Viscosity Testing for COVID-19

An article published recently in the MLO in the USA adds further evidence to the benefits of using plasma viscosity testing when managing patients suffering from COVID-19. It follows on from the study published by Addenbrookes Hospital in Cambridge earlier this year.

With the growing body of evidence for the use of plasma viscosity testing for managing COVID-19, now is the time to explore how our clinical viscometers can help healthcare professionals to better utilise their resources during the pandemic.

Click here to see the article


More News

Quality Manager (Incorporating Compliance & Regulatory Affairs)

We’re looking to recruit an experienced Quality Manager, specifically to drive our ISO 9001, 13485 and IVDR compliance. We’re looking...

Read More

Customer Service and Administration Officer

We’re looking to recruit a customer service and administration officer for our busy office in Pembrokeshire   This is a...

Read More

Manufacturing Assembler position at Benson Viscometers

As we continue to grow, especially into International markets, we’re looking to expand our manufacturing team and capabilities. We are...

Read More